BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8713793)

  • 21. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation of cross-linked fibrin by human leukocyte proteases.
    Francis CW; Marder VJ
    J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil proteases in plasminogen activation.
    Machovich R; Himer A; Owen WG
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):273-7. PubMed ID: 1715763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perturbation of the integrity of the blood-brain barrier by fibrinolytic enzymes.
    Nagy Z; Kolev K; Csonka E; Vastag M; Machovich R
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):471-8. PubMed ID: 9818996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmin is a specific stimulus of the 5-lipoxygenase pathway of human peripheral monocytes.
    Weide I; Tippler B; Syrovets T; Simmet T
    Thromb Haemost; 1996 Oct; 76(4):561-8. PubMed ID: 8902997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin G from patients with antiphospholipid syndrome impairs the fibrin dissolution with plasmin.
    Kolev K; Gombás J; Váradi B; Skopál J; Mede K; Pitlik E; Nagy Z; Machovich R
    Thromb Haemost; 2002 Mar; 87(3):502-8. PubMed ID: 11916083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase.
    Bonnefoy A; Legrand C
    Thromb Res; 2000 May; 98(4):323-32. PubMed ID: 10822079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot.
    Bagoly Z; Haramura G; Muszbek L
    Thromb Haemost; 2007 Aug; 98(2):359-67. PubMed ID: 17721618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of human polymorphonuclear neutrophil elastase, polymorphonuclear neutrophil cathepsin-G, and alpha 2-macroglobulin levels in healthy and inflamed dental pulps.
    Rauschenberger CR; McClanahan SB; Pederson ED; Turner DW; Kaminski EJ
    J Endod; 1994 Nov; 20(11):546-50. PubMed ID: 7543925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphonuclear leucocytes have two opposing roles in fibrinolysis.
    Moir E; Robbie LA; Bennett B; Booth NA
    Thromb Haemost; 2002 Jun; 87(6):1006-10. PubMed ID: 12083479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fibrinolysis and disseminated intravascular coagulation].
    Ikematsu S
    Rinsho Byori; 1985 Jun; Spec No 63():27-36. PubMed ID: 2931536
    [No Abstract]   [Full Text] [Related]  

  • 32. The elastase-mediated pathway of fibrinolysis.
    Machovich R; Owen WG
    Blood Coagul Fibrinolysis; 1990; 1(1):79-90. PubMed ID: 2151710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino acid-derived phthalimide and saccharin derivatives as inhibitors of human leukocyte elastase, cathepsin G, and proteinase 3.
    Groutas WC; Chong LS; Venkataraman R; Kuang R; Epp JB; Houser-Archield N; Huang H; Hoidal JR
    Arch Biochem Biophys; 1996 Aug; 332(2):335-40. PubMed ID: 8806743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
    Yavin EJ; Eisenstein M; Fridkin M
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosslinking kinetics of the human transglutaminase, factor XIII[A2], acting on fibrin gels and gamma-chain peptides.
    Lewis KB; Teller DC; Fry J; Lasser GW; Bishop PD
    Biochemistry; 1997 Feb; 36(5):995-1002. PubMed ID: 9033388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: a model for extravascular fibrinolysis.
    Carmassi F; de Negri F; Morale M; Song KY; Chung SI
    Semin Thromb Hemost; 1996; 22(6):489-96. PubMed ID: 9122713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced in vitro fibrinolytic activity of immobilized plasmin on collagen beads.
    Shankar H; Senatore F; Zuniga P; Venkataramani E
    J Biomed Mater Res; 1987 Jul; 21(7):897-912. PubMed ID: 2440893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hydrolytic properties of plasmin 1 and 2 and miniplasmin].
    Kastrikina TF; Taran LD; Kudinov SA
    Dokl Akad Nauk SSSR; 1984; 278(1):240-2. PubMed ID: 6237895
    [No Abstract]   [Full Text] [Related]  

  • 40. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.